Motus GI Holdings (STU:7M4) EBIT: €-9.23 Mil (TTM As of Mar. 2024)


STU:7M4 Motus GI Holdings Inc STU:7M4
12 GF Score
Price €6.36
View Full Analysis

What is Motus GI Holdings EBIT?

Motus GI Holdings STU:7M4 12 EBIT is €-9.23 Mil as of Mar. 2024. GuruFocus rates STU:7M4 with a GF Score™ of 12/100.

Motus GI Holdings's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was €-1.87 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was €-9.23 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Motus GI Holdings's annualized ROC % for the quarter that ended in Mar. 2024 was -269.46%. Motus GI Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -722.71%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Motus GI Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -923,400.00%.

Motus GI Holdings  (STU:7M4) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Motus GI Holdings's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-7.456 * ( 1 - 0% )/( (2.654 + 2.88)/ 2 )
=-7.456/2.767
=-269.46 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6.623 - 1.689 - ( 4.546 - max(0, 2.999 - 5.279+4.546))
=2.654

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6.501 - 1.375 - ( 4.548 - max(0, 3.044 - 5.29+4.548))
=2.88

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Motus GI Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-7.48/( ( (1.102 + max(-1.164, 0)) + (0.968 + max(-0.694, 0)) )/ 2 )
=-7.48/( ( 1.102 + 0.968 )/ 2 )
=-7.48/1.035
=-722.71 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.07 + 0.225 + 0.438) - (1.689 + 0 + 0.208)
=-1.164

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.075 + 0.21 + 0.457) - (1.375 + 0 + 0.061)
=-0.694

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Motus GI Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=-9.234/0.001
=-923,400.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Motus GI Holdings EBIT Related Terms

Motus GI Holdings EBIT Historical Data

* Premium members only.

The historical data trend for Motus GI Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Motus GI Holdings EBIT Chart

Motus GI Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only -21.09 -15.45 -16.21 -16.37 -11.10

Motus GI Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.87 -2.54 -2.30 -2.52 -1.87

STU:7M4 vs ABT, BSX, SYK: EBIT Comparison

For the Medical Devices subindustry, Motus GI Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Motus GI Holdings EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Motus GI Holdings's EV-to-EBIT falls into.


STU:7M4
12GF Score
Motus GI Holdings Inc STU:7M4
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Motus GI Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-9.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €-9.23 Mil mean?
Motus GI Holdings (STU:7M4) has a EBIT of €-9.23 Mil as of Mar. 2024. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Motus GI Holdings.
Is Motus GI Holdings' EBIT too high?
Motus GI Holdings' current EBIT is €-9.23 Mil. Overall, Motus GI Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Motus GI Holdings' EBIT compare to ABT and BSX?
Motus GI Holdings' EBIT of €-9.23 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Motus GI Holdings. Motus GI Holdings's current EBIT is €-9.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Motus GI Holdings stock overvalued right now?
Motus GI Holdings (STU:7M4) has a current EBIT of €-9.23 Mil. The current EBIT is €-9.23 Mil. Motus GI Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Motus GI Holdings (STU:7M4), the current EBIT is €-9.23 Mil as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Motus GI Holdings Business Description

Address 1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301
Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs, and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the FDA) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.
12GF Score

Get the complete analysis for STU:7M4

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.36
Price